Gene-edited chickens to combat bird flu: Saviour or liability?
By Claire Robinson,
GMWatch
| 10. 19. 2023
Chicken farm by "L214 - éthique et animaux"
from Wiki Commons, licensed under CC by 3.0.
Scientists at the University of Edinburgh’s Roslin Institute — the animal research centre where Dolly the sheep was created — have used CRISPR gene editing to develop chickens that resist infection by bird flu, a disease that has decimated some wild bird populations and commercial poultry flocks across the world. But there are serious risks and limitations in the research, which were even indicated by the scientists involved but were largely ignored or downplayed by mainstream media outlets.
A press statement by the Roslin called the gene-edited chickens a “significant step in bird flu fight” and said, “Alterations to key gene associated with infection offer partial protection and suggest [a] path to flu-resistant poultry”. The findings are published in Nature Communications.
The Roslin reported that the scientists used gene-editing techniques to identify and change parts of chicken DNA that could limit the spread of avian flu in the birds. The bird flu virus needs a protein present in chicken cells, ANP32A, to...
Related Articles
By Emily Mullin, Wired | 11.14.2023
In a small initial test in people, researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol, the fatty substance that clogs and hardens arteries over time.
The gene-editing treatment aims to permanently lower cholesterol...
By Carissa Wong, Nature | 11.16.2023
In a world first, the UK medicines regulator has approved a therapy that uses the CRISPR–Cas9 gene-editing tool as a treatment. The decision marks another high point for a biotechnology that has been lauded as revolutionary in the decade since...
By Emily Mullin, Wired | 11.16.2023
The first medical treatment that uses Crispr gene editing was authorized Thursday by the United Kingdom.
The one-time therapy, which will be sold under the brand name Casgevy, is for patients with sickle cell disease and a related blood disorder...
By Alexis Heng, UCA News | 11.13.2023
In recent years, Singapore has increasingly leveraged new reproductive technologies to overcome the country's rapidly aging demographics and dismal fertility rate, which hit a new low in 2022.
Hence, it would be timely for Singapore’s Bioethics Advisory Committee (BAC) to...